Everand Logo

Welcome to Everand!

  • STAT

    Trump’s new tone with drug makers: gratitude

    by Ike Swetlitz and Lev Facher Aug 08, 2018 2 minutes
    President Trump listens to health secretary Alex Azar speak in the Rose Garden.

    WASHINGTON — The drug industry’s much-publicized pledges not to hike their prices — however temporary they might be — are clearly keeping President Trump happy.

    Tuesday, at a dinner at his New Jersey golf course, Trump didn’t accuse the industry of or lament “RIPOFF” prices, as he has

    You’re reading a preview, subscribe to read more.

    More from STAT

    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About MorphoSys Drug Risks, An AstraZeneca Admission, And More
    MorphoSys is dealing with a safety issue with pelabresib, the experimental treatment for myelofibrosis and centerpiece of its proposed $3 billion acquisition by Novartis.
    STAT2 min readCrime & Violence
    STAT+: Pharmalittle: We’re Reading About A Medicare Price-negotiation Ruling, Pharma’s Slipping Reputation, And More
    A U.S. judge dealt a blow to two drugmakers challenging the authority for Medicare to negotiate the prices of prescription drugs.
    STAT2 min readAmerican Government
    STAT+: Pharmalittle: We’re Reading About FTC Reviewing Novo-Catalent Deal, Amneal Opioid Settlement, And More
    The FTC wants more information on a $16.5 million deal in which Novo Nordisk's parent company would purchase Catalent, a contract drug manufacturer.

    Related Books & Audiobooks